<DOC>
	<DOCNO>NCT00965887</DOCNO>
	<brief_summary>This study evaluate bioequivalence two solid dose formulation MK0974 .</brief_summary>
	<brief_title>Bioequivalence Two Tablet Forms MK0974 ( 0974-045 )</brief_title>
	<detailed_description />
	<criteria>Subject good health Subject nonsmoker Subject willing comply study restriction Subject history stroke , chronic seizure , major neurological disorder Subject history cancer Subject nursing mother Subject history disease condition might make participation study unsafe might confound result study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>